Europe Healthcare Bioconvergence Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Healthcare Bioconvergence Market, by Application
1.4.2 Europe Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Healthcare Bioconvergence Market by Application
3.1 Europe Drug Discovery Market by Country
3.2 Europe Precision Medicine Market by Country
3.3 Europe Regenerative Medicine Market by Country
3.4 Europe Diagnostic & Biological Sensors Market by Country
3.5 Europe Bioelectronics Market by Country
3.6 Europe Nanorobotics for Drug Delivery Market by Country
3.7 Europe Engineered Living Materials Market by Country
3.8 Europe Optogenetics Market by Country

Chapter 4. Europe Healthcare Bioconvergence Market by Country
4.1 Germany Healthcare Bioconvergence Market
4.1.1 Germany Healthcare Bioconvergence Market by Application
4.2 UK Healthcare Bioconvergence Market
4.2.1 UK Healthcare Bioconvergence Market by Application
4.3 France Healthcare Bioconvergence Market
4.3.1 France Healthcare Bioconvergence Market by Application
4.4 Russia Healthcare Bioconvergence Market
4.4.1 Russia Healthcare Bioconvergence Market by Application
4.5 Spain Healthcare Bioconvergence Market
4.5.1 Spain Healthcare Bioconvergence Market by Application
4.6 Italy Healthcare Bioconvergence Market
4.6.1 Italy Healthcare Bioconvergence Market by Application
4.7 Rest of Europe Healthcare Bioconvergence Market
4.7.1 Rest of Europe Healthcare Bioconvergence Market by Application

Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview